North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Growth Driven by High Prevalence of Diabetes
North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market is home to various market players including Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Paratek Pharmaceuticals, Inc., Melinta Therapeutics, Inc., Arrevus, Inc., AbbVie Inc., Aurobindo Pharma Ltd., Amneal Pharmaceuticals LLC, and Sun Pharmaceutical Industries Ltd. High prevalence of diabetes is expected to aid in growth of North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market . ABSSSIs are usually associated with diabetes, as their frequent presence results in a higher level of sugar in the bloodstream, which may ultimately cause diabetic complications. However, this is not always the case, and in fact, it appears that there is a strong relationship between chronic renal failure and complicated skin structures infections. This is probably due to the fact that the kidneys fail to eliminate wastes prope...